0928-0987
Monthly
No
EUR J PHARM SCI
1993
501
NETHERLANDS
http://www.elsevier.com/wps/find/journaldescription.cws_home/523997/description
約3.0個(gè)月審稿時(shí)間
容易平均錄用比例
3.532影響因子
藥學(xué)小學(xué)科
《歐洲藥物科學(xué)雜志》是歐洲藥物科學(xué)聯(lián)合會(huì)(EUFEPS)的官方期刊。該雜志出版的研究報(bào)告,評(píng)論文章和科學(xué)評(píng)論的所有方面的藥物科學(xué)的重點(diǎn)創(chuàng)新和科學(xué)質(zhì)量。編輯歡迎在這個(gè)多學(xué)科領(lǐng)域的文章,從藥物發(fā)現(xiàn),藥物交付到藥物開(kāi)發(fā)。更具體地說(shuō),該雜志在藥物化學(xué)、藥理學(xué)、藥物吸收和代謝、藥物動(dòng)力學(xué)和藥效學(xué)、藥物和生物醫(yī)學(xué)分析、藥物傳遞(包括基因傳遞、藥物靶向、藥物技術(shù)、藥物生物技術(shù)和臨床藥物評(píng)價(jià))等領(lǐng)域發(fā)表報(bào)告??茖W(xué)評(píng)論和評(píng)論文章一般只由編輯邀請(qǐng)或同意??茖W(xué)會(huì)議論文集可作為特刊或增刊出版。提交給《日刊》的稿件只有在下列條件下才被接受:(a)它們必須經(jīng)過(guò)編輯審查(一般由兩名獨(dú)立審稿人審查);(b)它們尚未、也將不會(huì)全部或部分發(fā)表在任何其他期刊上;(c)《赫爾辛基宣言》和《東京關(guān)于人類(lèi)的宣言》的建議以及《歐洲共同體關(guān)于使用實(shí)驗(yàn)動(dòng)物的公認(rèn)原則的準(zhǔn)則》已得到遵守。
http://ees.elsevier.com/ejps/
The European Journal of Pharmaceutical Sciences is the official journal of the European Federation for Pharmaceutical Sciences (EUFEPS). The journal publishes research reports, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with strong emphasis on originality and scientific quality. The Editors welcome articles in this multidisciplinary field, ranging from drug discovery, over drug delivery to drug development. More specifically, the Journal publishes reports in medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery including gene delivery, drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal. Manuscripts submitted to the Journal are only accepted on the understanding that (a) they are subject to editorial review (generally by two independent referees); (b) they have not been, and will not be, published in whole or in part in any other journal; (c) the recommendations of the Declarations of Helsinki and Tokyo, for humans, and the European Community guidelines as accepted principles for the use of experimental animals have been adhered to.
快速預(yù)審、投刊前指導(dǎo)、專(zhuān)業(yè)學(xué)術(shù)評(píng)審,對(duì)文章進(jìn)行評(píng)價(jià);
立即咨詢(xún)校對(duì)編輯、深度潤(rùn)色,讓稿件符合學(xué)術(shù)規(guī)范,格式體例等標(biāo)準(zhǔn);
立即咨詢(xún)適用于語(yǔ)句和結(jié)構(gòu)尚需完善和調(diào)整的中文文章,確保稿件達(dá)到要求;
立即咨詢(xún)數(shù)據(jù)庫(kù)包括:期刊、文章、書(shū)籍、會(huì)議、預(yù)印書(shū)、百科全書(shū)和摘要等;
立即咨詢(xún)讓作者在期刊選擇時(shí)避免走彎路,縮短稿件被接收的周期;
立即咨詢(xún)根據(jù)目標(biāo)期刊格式要求對(duì)作者文章進(jìn)行全面的格式修改和調(diào)整;
立即咨詢(xún)幫助作者將稿件提交至目標(biāo)期刊投稿系統(tǒng),降低退稿或拒稿率;
立即咨詢(xún)按照您提供的稿件內(nèi)容,指導(dǎo)完成投稿附信(cover letter);
立即咨詢(xún)大類(lèi)學(xué)科同領(lǐng)域優(yōu)質(zhì)期刊 | 大類(lèi)學(xué)科 | 小類(lèi)學(xué)科 | 影響因子 | 分區(qū) | ISSN |
---|---|---|---|---|---|
ACTA PHARMACEUTICA | 醫(yī)學(xué) | 藥學(xué) | 1.405 | N/A | 1330-0075 |
ACTA POLONIAE PHARMACEUTICA | 醫(yī)學(xué) | 藥學(xué) | 0.447 | N/A | 0001-6837 |
ADVANCED DRUG DELIVERY REVIEWS | 醫(yī)學(xué) | 藥學(xué) | 15.519 | N/A | 0169-409X |
ALCOHOL | 醫(yī)學(xué) | 藥學(xué) | 2.039 | N/A | 0741-8329 |
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 醫(yī)學(xué) | 藥學(xué) | 2.012 | N/A | 1079-2082 |
AMERICAN JOURNAL OF THERAPEUTICS | 醫(yī)學(xué) | 藥學(xué) | 1.133 | N/A | 1075-2765 |
ANNALS OF PHARMACOTHERAPY | 醫(yī)學(xué) | 藥學(xué) | 2.443 | N/A | 1060-0280 |
Annual Review of Pharmacology and Toxicology | 醫(yī)學(xué) | 藥學(xué) | 12.103 | N/A | 0362-1642 |
ANTIVIRAL RESEARCH | 醫(yī)學(xué) | 藥學(xué) | 4.13 | 2區(qū) | 0166-3542 |
Bangladesh Journal of Pharmacology | 醫(yī)學(xué) | 藥學(xué) | 0.811 | N/A | 1991-007X |
發(fā)現(xiàn)心儀選題請(qǐng)?zhí)顔?/b>
獲取發(fā)表周期短、審稿速度快容易錄用的期刊